Protein-induced Motor Fluctuations Despite Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion: A Case Report (P6-17.003)

Adriana Ochoa; Alexandra Ingram; Henry Moore

doi:10.1212/wnl.0000000000216460

June 9, 2026Neurology

Protein-induced Motor Fluctuations Despite Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion: A Case Report (P6-17.003)

View Full Paper

Ask AI

Bookmark

Share

Key Points

This case report aims to explore the effects of protein intake on foscarbidopa/foslevodopa infusion in advanced Parkinson's disease.
Descriptive case report outlining the patient's symptoms and treatment regimen.
Assessment of motor fluctuations related to protein intake and medication infusion.
Monitoring the patient's response to dietary changes.
Patient experienced exacerbation of parkinsonism symptoms coinciding with increased protein intake.
Continuous subcutaneous infusion of fCD/fLD was unable to mitigate the effects of protein consumption.

Implication

Case report reveals worsening parkinsonism with protein intake despite continuous foscarbidopa/foslevodopa infusion.

Abstract

This is the first case report regarding the interaction between protein intake and foscarbidopa/foslevodopa (fCD/fLD) subcutaneous infusion, leading to worsening of parkinsonism in a patient with advanced Parkinson’s disease.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ochoa et al. (2026) studied this question.

synapsesocial.com/papers/6a2cf3b4faef96ed7f05637c https://doi.org/10.1212/wnl.0000000000216460

View Full Paper

Ask AI

Bookmark

Share

Protein-induced Motor Fluctuations Despite Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion: A Case Report (P6-17.003)

Key Points

Implication

Abstract

Discussion

Cite This Study

Protein-induced Motor Fluctuations Despite Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion: A Case Report (P6-17.003)

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading